rhPSMA 7.3 (18F)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for rhPSMA 7.3 (18F), covering 2025-02-26 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy [Phase 3]